Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Calvet

Showing results (101-110 of 230) with videos related to

Pageof 23
Sort By:
Annals of Hematology|January 23, 2009
H. pylori eradication does not reduce paraprotein levels in monoclonal gammopathy of unknown significance (MGUS): a prospective cohort studyJuan-Alfonso Soler, Mercé Güell, Meritxell Bricullé, et al.
Revista Espanola De Enfermedades Digestivas|January 12, 2018
Inter and intra-observer concordance for the diagnosis of portal hypertension gastropathyMeritxell Casas, Mercedes Vergara, Enric Brullet, et al.
Inflammatory Bowel Diseases|May 16, 2019
A Prospective Pilot Randomized Study: Electroacupuncture vs. Sham Procedure for the Treatment of Fatigue in Patients With Quiescent Inflammatory Bowel DiseaseDiana Horta, Alba Lira, Meritxell Sanchez-Lloansi, et al.
Journal of Proteome Research|September 24, 2020
Analysis of the Association between Fatigue and the Plasma Lipidomic Profile of Inflammatory Bowel Disease PatientsDiana Horta, Marta Moreno-Torres, María José Ramírez-Lázaro, et al.
Gastroenterologia Y Hepatologia|May 20, 2023
Risks, indications and technical aspects of colonoscopy in elderly or frail patients. Position paper of the Societat Catalana de Digestologia, the Societat Catalana de Geriatria i Gerontologia and the Societat Catalana de Medicina de Familia i ComunitariaSalvador Machlab, Esther Francia, Juanjo Mascort, et al.
International Journal of Clinical Practice|September 5, 2017
Fourteen-day high-dose esomeprazole, amoxicillin and metronidazole as third-line treatment for Helicobacter pylori infectionIgnasi Puig, Jesús M González-Santiago, Javier Molina-Infante, et al.
The Journal of Antimicrobial Chemotherapy|June 17, 2015
Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infectionSheila López-Góngora, Ignasi Puig, Xavier Calvet, et al.
Gastroenterologia Y Hepatologia|December 2, 2015
Outcome after a dose "de-intensification" strategy with anti-TNF drugs in patients with Crohn's diseaseMaría Chaparro, Manuel Barreiro-de Acosta, Esther García-Planella, et al.
Journal of Clinical Medicine|September 11, 2020
Time Trends of Crohn's Disease in Catalonia from 2011 to 2017. Increasing Use of Biologics Correlates with a Reduced Need for SurgeryEduard Brunet, Emili Vela, Luigi Melcarne, et al.
Inflammatory Bowel Diseases|February 25, 2014
The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: serial observations in 37 patientsAlicia Algaba, Pablo M Linares, M Encarnación Fernández-Contreras, et al.
Pageof 23

Showing results (101-110 of 230) with videos related to

Sort By:
Pageof 23
Annals of Hematology|January 23, 2009
H. pylori eradication does not reduce paraprotein levels in monoclonal gammopathy of unknown significance (MGUS): a prospective cohort studyJuan-Alfonso Soler, Mercé Güell, Meritxell Bricullé, et al.
Revista Espanola De Enfermedades Digestivas|January 12, 2018
Inter and intra-observer concordance for the diagnosis of portal hypertension gastropathyMeritxell Casas, Mercedes Vergara, Enric Brullet, et al.
Inflammatory Bowel Diseases|May 16, 2019
A Prospective Pilot Randomized Study: Electroacupuncture vs. Sham Procedure for the Treatment of Fatigue in Patients With Quiescent Inflammatory Bowel DiseaseDiana Horta, Alba Lira, Meritxell Sanchez-Lloansi, et al.
Journal of Proteome Research|September 24, 2020
Analysis of the Association between Fatigue and the Plasma Lipidomic Profile of Inflammatory Bowel Disease PatientsDiana Horta, Marta Moreno-Torres, María José Ramírez-Lázaro, et al.
Gastroenterologia Y Hepatologia|May 20, 2023
Risks, indications and technical aspects of colonoscopy in elderly or frail patients. Position paper of the Societat Catalana de Digestologia, the Societat Catalana de Geriatria i Gerontologia and the Societat Catalana de Medicina de Familia i ComunitariaSalvador Machlab, Esther Francia, Juanjo Mascort, et al.
International Journal of Clinical Practice|September 5, 2017
Fourteen-day high-dose esomeprazole, amoxicillin and metronidazole as third-line treatment for Helicobacter pylori infectionIgnasi Puig, Jesús M González-Santiago, Javier Molina-Infante, et al.
The Journal of Antimicrobial Chemotherapy|June 17, 2015
Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infectionSheila López-Góngora, Ignasi Puig, Xavier Calvet, et al.
Gastroenterologia Y Hepatologia|December 2, 2015
Outcome after a dose "de-intensification" strategy with anti-TNF drugs in patients with Crohn's diseaseMaría Chaparro, Manuel Barreiro-de Acosta, Esther García-Planella, et al.
Journal of Clinical Medicine|September 11, 2020
Time Trends of Crohn's Disease in Catalonia from 2011 to 2017. Increasing Use of Biologics Correlates with a Reduced Need for SurgeryEduard Brunet, Emili Vela, Luigi Melcarne, et al.
Inflammatory Bowel Diseases|February 25, 2014
The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: serial observations in 37 patientsAlicia Algaba, Pablo M Linares, M Encarnación Fernández-Contreras, et al.
Pageof 23